Lupin Pharmaceuticals, Inc.
Lupin Pharmaceuticals, Inc., a prominent player in the global pharmaceutical industry, is headquartered in the United States. Founded in 1968, the company has established a strong presence in various operational regions, including North America, Europe, and Asia. Specialising in generic and branded medications, Lupin focuses on therapeutic areas such as cardiovascular, diabetes, and central nervous system disorders.
With a commitment to innovation, Lupin has achieved significant milestones, including numerous FDA approvals and a robust pipeline of products. Their core offerings, which include high-quality generics and specialty pharmaceuticals, are distinguished by their efficacy and affordability. As a leading manufacturer, Lupin Pharmaceuticals is recognised for its market position, consistently ranking among the top generic drug producers in the US, reflecting its dedication to improving patient outcomes worldwide.
+25 vs industry average
Lupin Pharmaceuticals, Inc.’s score of 63 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Lupin Pharmaceuticals, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Lupin Pharmaceuticals, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Lupin Pharmaceuticals, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Lupin Pharmaceuticals, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Lupin Limited
Carbon Disclosure Project
Inherited from Lupin Limited
The Climate Pledge
Inherited from Lupin Limited
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Lupin Pharmaceuticals, Inc.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project